GetWiki

{{Short description|American multinational pharmaceutical and consumer goods corporation}}{{Distinguish|S. C. Johnson & Son}}{{Redirect|J&J|other uses|J & J (disambiguation)}}{{Use American English|date=October 2015}}{{Use mdy dates|date=May 2023}}

factoids
name	Johnson & Johnson| logo = JNJ Logo New.svg| logo_size = 260px| image = JohnsonJohnson HQ building.jpg| image_size = 250px Johnson and Johnson Plaza in New Brunswick, New Jersey>New Brunswick, New Jersey Public company>Public| traded_as = {hide}Unbulleted list | DJIA component | S&P 100 component | S&P 500 component {edih}	sl=n	US4781601046}}| industry = {hide}Unbulleted list | Pharmaceutical | Medical Technology {edih}	New Brunswick, New Jersey, United States| founders = {hide}Unbulleted list | Robert Wood Johnson I | James Wood Johnson | Edward Mead Johnson {edih}| location = Johnson and Johnson Plaza| location_city = New Brunswick, New Jersey	40	55	74	37	format=dms	display=title,inline}}| area_served = Worldwide| key_people = {hide}Unbulleted list | Joaquin Duato |(Chairman & CEO) {edih}| products = List of Johnson & Johnson products and services	85.16 billion|link=yes}} (2023)	21.21 billion}} (2023)	35.15 billion}} (2023)	167.6 billion}} (2023)	68.78 billion}} (2023)| num_employees = 134,400 (2023)| subsid = {hide}Unbulleted list | Abiomed | Acclarent | Actelion | Cilag | DePuy Synthes | Ethicon | Janssen Biotech | Janssen Pharmaceuticals | Janssen Vaccines | Johnson & Johnson Vision | Mentor | Synthes {edih}	weblink|jnj.com}}		DATE=FEBRUARY 16, 2024, U.S. Securities and Exchange Commission, }}Johnson & Johnson (J&J) is an American multinational, pharmaceutical, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 40 on the 2023 Fortune 500 list of the largest United States corporations. In 2023, the company was ranked 40th in the Forbes Global 2000.WEB, en,weblink The Global 2000 2023, Forbes, 2024-02-07, 2024-01-29,weblink Johnson & Johnson has a global workforce of approximately 130,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato.Johnson & Johnson was founded in 1886 by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, selling ready-to-use sterile surgical dressings. In 2023, the company split off its consumer healthcare business sector into a new publicly traded company, Kenvue. The company is exclusively focused on developing and producing pharmaceutical prescription drugs and medical device technologies.Johnson & Johnson is one of the world's most valuable companies and is one of only two U.S.-based companies that has a prime credit rating of AAA.WEB, 2023-08-03, Looking to Bet On Perfect AAA Credit Ratings? Play These ETFs,weblink 2023-08-24, Yahoo Finance, en-US, History 1873–1885: Before Johnson & Johnson Robert Wood Johnson began his professional training at age 16 as a pharmaceutical apprentice at an apothecary run by his mother's cousin, James G. Wood, in Poughkeepsie, New York.NEWS, November 12, 2000, Carbondale Area Native Founded Johnson & Johnson, 129, The Times-Tribune,weblink October 28, 2020, BOOK, Foster LG, The Gentleman Rebel, Lillian Press, 1999, 0966288203, {{Rp|12}} Johnson co-founded his own company with George Seabury in 1873. The New York-based Seabury & Johnson became known for its medicated plasters.BOOK, Ingham JN, Biographical Dictionary of American Business Leaders, Greenwood Publishing Group, 1983, 0313239088, 2, {{Rp|675}}{{Rp|15}} Robert Wood Johnson represented the company at the 1876 World's Fair.JOURNAL, Rutkow I, Joseph Lister and his 1876 tour of America, Annals of Surgery, 257, 6, 1181–7, June 2013, 23059499, 10.1097/SLA.0b013e31826d9116, 389275, WEB, World's Fair in Philadelphia : Johnson & Johnson Our Story,weblink October 23, 2020, ourstory.jnj.com, There he heard Joseph Lister's explanation of a new procedure: antiseptic surgery.{{Rp|31}} Johnson parted ways with his business partner Seabury in 1885.{{Rp|38}} 1886: Founding of Johnson & Johnson (File:Robert-wood-johnson-i.jpg|thumb|180px|right|Robert Wood Johnson)(File:Johnson and Johnson corrosive sublimate cotton.jpg|thumb|Early corrosive sublimate cotton packaging with the signature logo)Robert Wood Johnson joined his brothers, James Wood Johnson and Edward Mead Johnson, and created a line of ready-to-use sterile surgical dressings in 1886. They founded Johnson & Johnson in 1886{{Rp|675}}{{Rp|38}} with 14 employees, eight women and six men.{{Rp|43}} Johnson & Johnson opened its first factory building in the old Janeway and Carpenter factory on Neilson Street in New Brunswick, New Jersey.NEWS, Gordon, A. E., March 16, 1994, The New Enterprise, The New Brunswick Times, They manufactured sterile surgical supplies, household products, and medical guides.WEB, History of Johnson & Johnson – TheStreet,weblink October 23, 2020, www.thestreet.com, February 24, 2020, Those products initially featured a logo that resembled the signature of James Wood Johnson.NEWS, Warner S, April 10, 2005, From Band-Aids To Biotech (Published 2005), en-US, The New York Times,weblink October 23, 2020, 0362-4331, Robert Wood Johnson served as the first president of the company.{{Rp|675}} 1887–1942: Early history The company sold medicated plasters such as Johnson & Johnson's Black Perfect Taffeta Court PlasterBOOK, Pharmaceutische Rundschau, Fr. Hoffmann, 1888, 6, Harvard University, 181, and also manufactured the world's first sterile surgical products, including sutures, absorbent cotton, and gauze.BOOK, McDonnell G, Block's Disinfection, Sterilization, and Preservation, Lippincott Williams & Wilkins, 2020, 978-1496381507, The company published "Modern Methods of Antiseptic Wound Treatment", a guide on how to do sterile surgery using its products, and in 1888, distributed 85,000 copies to doctors and pharmacists across the United States.BOOK, Pickersgill HE, Frederick Barnett Kilmer in History of Middlesex County, New Jersey 1664- 1920, Lewis Historical Publishing Company, 1921, New York and Chicago, {{Rp|3–99}} The manual was translated into three languages and distributed worldwide. The first commercial first aid kit was designed in 1888 to support railroad construction workers, who were often hundreds of miles from medical care. The kits included antiseptic emergency supplies and directions for field use. In 1901, the company published the Handbook of First Aid, a guide on applying first aid.In 1889, the company hired pharmacist Fred Kilmer as its first scientific director, who led its scientific research and wrote educational manuals. Kilmer's first achievement as scientific director was developing the industrial sterilization process. He was employed at the company until 1934.Johnson & Johnson had more than 400 employees and 14 buildings by 1894.WEB, 1893, 1907, 1929 and Today,weblink October 23, 2020, Kilmer House, en, In 1894, the company began producing Johnson's Baby Powder, the company's first baby product.The company introduced the world's first maternity kit in 1894 to aid at-home births, called Dr. Simpson's Maternity Packet, presumably after Scottish obstetrician James Young Simpson. The kit included a washcloth; safety pins; sterile sutures, sponges, and gauze; antiseptic soap; an obstetric sheet and ligatures; flannel to wrap the baby in; and a chart for keeping birth records.WEB, Jenkins, Elizabeth, May 11, 2017, Oh, Baby! Why Johnson & Johnson Created Dr. Simpson's Maternity Packets,weblink May 24, 2023, Johnson & Johnson, The products were later marketed separately, including "Lister's Towels", the world's first mass-produced sanitary napkins.WEB, Lister's Towels, Johnson & Johnson, ads at MUM,weblink October 23, 2020, www.mum.org, NEWS, February 26, 2020, How did companies sell 'unmentionable' sanitary towels?, en-GB, BBC News,weblink October 23, 2020, Kilmer wrote "Hygiene in Maternity", an instructional guide for mothers before and after delivery.BOOK,weblink Red Cross Notes, 1898, Johnson & Johnson., en, In 1904, the company expanded its baby care products with "Lister's Sanitary Diapers", a diaper product for infants.WEB, Facts about disposable diapers as P&G celebrates 50 years in Cape County,weblink October 28, 2020, Southeast Missourian, During the Spanish–American War, Johnson & Johnson developed and donated 300,000 packaged compressed surgical dressings for soldiers in the field{{Rp|78}} and created a trauma stretcher for field medics. The company donated its products in disaster relief efforts of the 1900 Galveston hurricane{{Rp|79}} and the 1906 San Francisco earthquake.{{Rp|81}}Johnson & Johnson vaccinated all of its employees against smallpox during the 1901 smallpox epidemic. The firm employed more than 1,200 people by 1910.NEWS, March 28, 1911, Peril of City Factories, Daily Home News, New Brunswick, N.J., Women accounted for half of the company's workforce and led a quarter of its departments.Robert Wood Johnson died in 1910, and he was succeeded as president of the company by his brother James Wood Johnson.{{Rp|195}}During World War I, Johnson & Johnson factories increased production to meet wartime demands for sterile surgical products.WEB, World War I Centennial: How the Great War Changed Johnson & Johnson,weblink October 24, 2020, Kilmer House, en, WEB, About Us,weblink October 24, 2020, Chicopee Solutions, en-us, In 1916, the company acquired Chicopee Manufacturing Company in Chicopee Falls, Massachusetts, to meet demand.{{Rp|129}} Near the end of World War I, the 1918 flu pandemic broke out. The company invented and distributed an epidemic mask that helped prevent the spread of the flu.WEB, Epidemic Mask – Johnson & Johnson Our Story,weblink October 24, 2020, ourstory.jnj.com, November 29, 2020,weblink dead, WEB, History of Johnson & Johnson – FundingUniverse,weblink October 24, 2020, www.fundinguniverse.com, In 1919, Johnson & Johnson opened the Gilmour Plant near Montreal, its first factory outside the United States, which produced surgical products for international customers. In 1924 the company's first overseas manufacturing facility was opened in Slough, England.In 1920, Earle Dickson combined two Johnson & Johnson products, adhesive tape and gauze, to create the first commercial adhesive bandage. Band-Aid Brand Adhesive Bandages began sales the following year. In 1921, the company released Johnson's Baby Soap.BOOK,weblink Marketing Communications, 1921, en, Named after its Massachusetts facility, Johnson & Johnson built a textile mill and company town, Chicopee, outside Gainesville, Georgia.{{Rp|170}} In the 1930s, the company expanded operations to Argentina, Brazil, Mexico, and South Africa.WEB, Sengupta N, Johnson & Johnson: Caring for People, Worldwide,weblink October 8, 2020, Shri Dharmasthala Manjunatheshwara Institute for Management Development, In 1931, Johnson & Johnson introduced the first prescription contraceptive gel marketed as Ortho-Gynol.WEB, 1936 Magazine Print Advertisement Ortho Gynol Feminine Jelly Johnson & Johnson,weblink October 23, 2020, Advintage Plus, en, October 26, 2020,weblink" title="web.archive.org/web/20201026045534weblink">weblink dead, Robert Wood Johnson II became president of the company in 1932.{{Rp|195}}During The Great Depression Johnson & Johnson kept all its workers employed and raised wages by 5%.{{Rp|191}} In 1933, Robert Wood Johnson II wrote a letter to Franklin D. Roosevelt, calling for a federal law to increase wages and reduce hours for all American workers.{{Rp|199}} The company also opened a new facility in Chicago during that period.{{Rp|191}} Johnson wrote and distributed "Try Reality: A Discussion of Hours, Wages, and The Industrial Future" to persuade business leaders to follow his lead, advocating that business is more than profit and that companies have responsibilities to consumers, employees, and society. In "Try Reality", the section titled "An Industrial Philosophy" would later become the company's credo.{{Rp|224}}In 1935, Johnson's Baby Oil was added to its line of baby products.BOOK,weblink LIFE, August 9, 1943, Time (magazine), Time, en, WEB, Old School Products That Still Rock,weblink October 23, 2020, www.yahoo.com, June 22, 2014, en-US, Both male and female Johnson & Johnson employees were drafted and enlisted during World War II.WEB, First Peacetime Draft Enacted Just Before World War II,weblink October 23, 2020, U.S. Department of Defense, en-US, WEB, August 15, 2016, World War I Draft Registration Cards,weblink October 23, 2020, National Archives, en, The company ensured no one would lose their job when they returned home. Robert Wood Johnson II was appointed head of the Smaller War Plants Corporation in Washington, D.C. His work ensured U.S. factories with under 500 employees were awarded government contracts.WEB, Johnson & Johnson Helped by the Healing Powers of Innovation, the Johnson Family Found a Health-Care Empire Inside the Family Medicine Chest. That's Opened up Endless Opportunities. April 1, 2003,weblink October 23, 2020, money.cnn.com, NEWS, January 31, 1968, Robert Wood Johnson, 74, Dies; Chairman of Johnson & Johnson; Founder's Son Led Company until 1963 No. 2 Man on War Production Board (Published 1968), en-US, The New York Times,weblink October 23, 2020, 0362-4331, 1943: Credo and going public In 1943, as the company was preparing for its initial public offering (IPO), Robert Wood Johnson wrote what the company would call, "Our Credo",WEB, Our Credo,weblink November 29, 2020, Content Lab U.S., en, a defining document that has been used to guide the company's decisions over the years.WEB,weblink Johnson & Johnson's new CEO emphasizes company credo at shareholder's meeting, Todd S, NJ.com, April 26, 2012, March 13, 2020, The company completed its IPO and became a public company in 1944.WEB,weblink If You Invested $10,000 in Johnson & Johnson's IPO, This Is How Much Money You'd Have Now, Carmichael T, fool.com, December 31, 2019, March 13, 2020, In 1943, Vesta Stoudt identified a need for waterproof tape for ammunition boxes in World War Two. She wrote to Franklin D. Roosevelt with the idea; the president commissioned Revolite, a subsidiary of Johnson & Johnson at the time, to develop and manufacture a cloth-based adhesive tape.WEB, May 6, 2015, October 24, 1943 – COULDN'T KEEP HER IDEA DOWN {{!, Chicago Tribune Archive |url=http://archives.chicagotribune.com/1943/10/24/page/1/article/couldnt-keep-her-idea-down/ |access-date=August 30, 2022 |archive-url=https://web.archive.org/web/20150506050728weblink |archive-date=May 6, 2015 }} 1944–1999: Acquisitions and international expansion (File:Johnson and Johnson Logo.svg|thumb|Former logo used until 2023.)In 1944, the company began selling Johnson's Baby Lotion. The same year, the company established Ethicon Suture Laboratories. In 1947, G. F. Merson Ltd. was acquired to expand the company's suture business in the United Kingdom. The company was rebranded and absorbed into Ethicon.WEB, January 10, 2016, ETHICON History,weblinkweblink" title="web.archive.org/web/20160110154950weblink">weblink January 10, 2016, August 30, 2022, Johnson & Johnson chairman of the board, Robert Wood Johnson, published Or Forfeit Freedom, in 1947. The book outlined that businesses need to develop sustainable methods of using natural resources for the future of business and the planet.WEB, Robert Wood Johnson II Writes Or Forfeit Freedom {{!, Johnson & Johnson Our Story |url=https://ourstory.jnj.com/johnson-writes-or-forfeit-freedom |access-date=August 30, 2022 |website=ourstory.jnj.com}}In 1955, Ethicon developed a micro-point reverse-cutting ophthalmic needle attached to the suture. Micro-point surgical needles and sutures allowed for advances in modern vision surgery.WEB, December 3, 2014, A Comparison of Suturing Needles Available,weblink August 30, 2022, The Apprentice Doctor, en-US, JOURNAL, Byrne, Miriam, Aly, Al, March 14, 2019, The Surgical Needle,weblink Aesthetic Surgery Journal, 39, Suppl_2, S73–S77, 10.1093/asj/sjz035, 1527-330X, 30869752, In 1956, the company opened its first Asia-based operating company in the Philippines.WEB, Johnson & Johnson Expands to the Philippines {{!, Johnson & Johnson Our Story |url=https://ourstory.jnj.com/johnson-johnson-expands-philippines |access-date=August 30, 2022 |website=ourstory.jnj.com}} The following year, an operating company opened in India.WEB, Expanding to India {{!, Johnson & Johnson Our Story |url=https://ourstory.jnj.com/expanding-india |access-date=August 30, 2022 |website=ourstory.jnj.com}}WEB, Johnson & Johnson Private Limited – Manufacturer from Jogeshwari (E), Mumbai, India {{!, About Us |url=https://www.indiamart.com/jnj-india/profile.html |access-date=August 30, 2022 |website=www.indiamart.com}}WEB, Check, The Company, Johnson & Johnson Private Limited – Company Details {{!, The Company Check |url=https://www.thecompanycheck.com/company/johnson-johnson-private-limited/U33110MH1957PTC010928 |access-date=August 30, 2022 |website=www.thecompanycheck.com |language=en-IN}}In 1959, Johnson & Johnson acquired McNeil Laboratories.WEB, February 26, 2021, A history of Johnson & Johnson,weblink August 30, 2022, pharmaphorum.com, en-GB, A year later, the company sold Tylenol for the first time without a prescription. In the same year, Cilag Chemie joined Johnson & Johnson as Cilag. In 1961, Johnson & Johnson acquired Janssen Pharmaceuticals, which had been founded in 1953 by Belgian scientist Paul Janssen, the inventor of Fentanyl.WEB, 2024-02-06,weblink NPR, In 1963, Philip B. Hofmann succeeded Robert Wood Johnson as chairman and CEO. He was the first non-Johnson family member to become chief executive. Hofmann also helped found the Robert Wood Johnson Foundation. In the same year, the Food and Drug Administration approved a synthetic hormone contraceptive pill, Ortho-Novum.WEB, Ortho-Novum Oral Contraceptive,weblink August 30, 2022, National Museum of American History, en, In 1965, Johnson & Johnson acquired Codman & Shurtleff. The acquired company produced neurovascular devices and neurosurgery technologies.WEB, Winokoor, Charles, Johnson & Johnson's Codman & Shurtleff surgical instrument line sold to Indiana company,weblink August 30, 2022, Taunton Daily Gazette, en-US, In 1968, the company developed the RhoGAM vaccine. The vaccine prevented Rh hemolytic disease in newborns.WEB, February 22, 2018, RhoGAM at 50: A Columbia Drug Still Saving Lives of Newborns,weblink August 30, 2022, Columbia University Irving Medical Center, en, In 1969, Ortho Diagnostics, a company subsidiary, launched the Sickledex Tube Test for detecting anemia.JOURNAL, Henry, R. L., Nalbandian, R. M., Nichols, B. M., Camp, F. R., Conte, N. F., Wolf, P. L., April 1, 1971, Modified Sickledex tube test: a specific test for S hemoglobin,weblink Clinical Biochemistry, en, 4, 1, 196–207, 10.1016/S0009-9120(71)91504-9, 5143535, 0009-9120, The same year, the FDA approved the Johnson & Johnson arterial graft.WEB, August 8, 2021, Coronary Artery Bypass Graft Surgery,weblink August 30, 2022, www.hopkinsmedicine.org, en, In 1971, the company launched Hapindex Diagnostic Test, a rapid hepatitis B test for blood donors. The test was developed to prevent the spread of hepatitis B through blood transfusions.JOURNAL, Caul, E. O., Roberts, P. C., December 1974, An evaluation of low voltage counterimmuno-electrophoresis for the detection of hepatitis-B antigen (HB Ag), Journal of Clinical Pathology, 27, 12, 990–993, 10.1136/jcp.27.12.990, 0021-9746, 4156037, 475570, In the 1970s, Johnson & Johnson hired Henry N. Cobb from Pei Cobb Freed & Partners to design its new headquarters.WEB, Learning from our Late-Modern Legacy,weblink 2023-06-22, www.docomomo-us.org, en, The firm designed Johnson & Johnson Plaza across the railroad tracks from the older section of the Johnson & Johnson campus.BOOK, Dorothea, Berkhout, New Brunswick, New Jersey, The Decline and Revitalization of Urban America, Listokin, David, Hughes, James, Rutgers University Press, 2016, 978-0813575148, In 1973, Richard Sellars became chairman and CEO of Johnson & Johnson.NEWS, Abelson, Reed, June 27, 2010, Richard B. Sellars, Former Chief of Johnson & Johnson, Dies at 94, en-US, The New York Times,weblink August 30, 2022, 0362-4331, In 1976, James E. Burke became the company's chairman and CEO. During Burke's tenure, he managed the 1982 Tylenol tampering incident. It became a case study on crisis management. Under his leadership, the company recalled 31 million bottles of Tylenol, relaunched the product with a triple tamper-evident seal, and urged consumers not to use if tampered with. These practices became the pharmaceutical and packaged food industry norm.NEWS, Hilts, Philip J., November 12, 1982, Tylenol Is Reintroduced In Triple-Sealed Package, en-US, The Washington Post,weblink August 30, 2022, 0190-8286, Johnson & Johnson opened operating companies in China and Egypt in 1985. In 1987, Acuvue contact lenses became the first disposable contact lenses available to consumers. The lenses lasted up to one week, reducing the cost of contact lenses. In the same year, the company launched One Touch, a blood glucose monitoring system. In 1989, Ralph S. Larsen was appointed chairman and CEO of the company.WEB, October 20, 2012, Ralph S. Larsen – Robert Wood Johnson Foundation,weblinkweblink" title="web.archive.org/web/20121020073724weblink">weblink October 20, 2012, August 30, 2022, After the dissolution of the Soviet Union, Johnson & Johnson expanded into eastern Europe. By 1991, the company had a presence in Hungary, Russia, the Czech Republic, and Poland.WEB, Johnson & Johnson Reaches Eastern Europe {{!, Johnson & Johnson Our Story |url=https://ourstory.jnj.com/johnson-johnson-reaches-eastern-europe |access-date=August 30, 2022 |website=ourstory.jnj.com}} In the 1990s, the company acquired many familiar consumer health brands that made up the Johnson & Johnson family of companies. These acquisitions included Clean & Clear, Neutrogena, Motrin, and Aveeno.WEB, History of Johnson & Johnson – FundingUniverse,weblink August 30, 2022, www.fundinguniverse.com, Johnson & Johnson opened an operating company in Israel in 1996.WEB, Johnson & Johnson Opens in Israel {{!, Johnson & Johnson Our Story |url=https://ourstory.jnj.com/johnson-johnson-opens-israel |access-date=August 30, 2022 |website=ourstory.jnj.com}} In 1997, Johnson & Johnson acquired Biosense Webster. DePuy was acquired by Johnson & Johnson in 1998, rolling it into the Medtech business group. 2000–present William C. Weldon was appointed chairman and CEO of the company in 2002.NEWS, February 21, 2012, Johnson & Johnson CEO Weldon to step down in April, en, Reuters,weblink August 30, 2022, In 2003, Ethicon launched Vicryl Plus Antibacterial Sutures. The products prevent post-surgery infection within stitches. In 2006, Johnson & Johnson acquired Pfizer's consumer healthcare business and merged it with its consumer healthcare business group. The acquisition added brands like Listerine, Bengay, and Neosporin to the company's portfolio.WEB, June 27, 2006, J&J Buys Pfizer Consumer Healthcare Biz for $16.6 Billion,weblink August 30, 2022, Chief Marketer, en-US, In the same year, Johnson & Johnson's Janssen Pharmaceuticals, launched Prezista, a protease inhibitor for patients with failed previous HIV therapies.NEWS, April 4, 2007, AIDS drug Prezista performs well in new study, en, Reuters,weblink November 7, 2022, WEB, J&J's 800mg Prezista launched in UK – Pharmaceutical industry news,weblink November 7, 2022, www.thepharmaletter.com, In 2008, Johnson & Johnson acquired Mentor Corporation for $1 billion and merge its operations into Ethicon. In 2009, the company acquired HealthMedia, later renamed to Health & Wellness Solutions and the Human Performance Institute. In October 2010, J&J acquired Crucell for $2.4 billion. The subsidiary operates as the centre for vaccines, within Johnson & Johnson pharmaceuticals business group.WEB, Johnson & Johnson Acquires Vaccine Developer Crucell,weblink November 7, 2022, BioPharm International, March 8, 2011, en, In 2012, Alex Gorsky became chairman and CEO of Johnson & Johnson.WEB, Murphy, Tom, J&J CEO Gorsky to step down, company veteran to lead in 2022,weblink August 30, 2022, ABC News, en, In November 2015, Biosense Webster, Inc. acquired Coherex Medical Inc. expanding the company's range of treatment options for patients with atrial fibrillation.WEB, Perriello, Brad, November 20, 2015, J&J's Biosense Webster buys Coherex Medical and its WaveCrest anti-stroke device,weblink November 7, 2022, MassDevice, en-US, In 2017, Johnson & Johnson acquired Abbott Medical Optics from Abbott Laboratories for $4.325 billion, adding the new division into Johnson & Johnson Vision Care, Inc. in 2017.WEB, Johnson & Johnson Vision to acquire TearScience,weblink August 30, 2022, www.healio.com, en, That same year, Johnson & Johnson acquired Actelion in a $30 billion deal, the largest ever purchase by the company. After the purchase, Johnson & Johnson spun off Actelion's research and development unit into a separate legal entity.NEWS, January 26, 2017, Johnson & Johnson refills drug cabinet with $30 billion Actelion deal, en, Reuters,weblink August 30, 2022, In July 2017, Johnson & Johnson Vision Care, Inc acquired TearScience. In September 2017, the company acquired subscription-based contact lens startup Sightbox. In September of the same year Johnson & Johnson Medical GmbH acquired Emerging Implant Technologies GmbH, manufacturer of 3D-printed titanium interbody implants for spinal fusion surgery.WEB, Johnson & Johnson Medical GmbH Acquires Emerging Implant Technologies GmbH to Enhance Global Offering of Interbody Spine Implants,weblink August 30, 2022, BioSpace, en-US, In March 2019, the FDA approved esketamine for the treatment of severe depression, which is marketed as Spravato by Janssen Pharmaceuticals.WEB, Commissioner, Office of the, March 24, 2020, FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor's office or clinic,weblink August 30, 2022, FDA, en, WEB, January 29, 2019, SPRAVATO – Overview,weblink August 30, 2022, Janssen CarePath, en, In 2019, Johnson & Johnson announced the release of photochromic contact lenses. The lenses adjust to sunlight and help eyes recover from bright light exposure faster. The lenses contain a photochromic additive that adapts visible light amounts filtered to the eyes and are the first to use such additives.WEB, Research, National Center for Toxicological, March 24, 2020, FDA clears first contact lens with light-adaptive technology,weblink August 30, 2022, FDA, en, In November 2020, Johnson & Johnson acquired Momenta Pharmaceuticals for $6.5 billion.NEWS, August 19, 2020, Johnson & Johnson to buy biotech Momenta in $6.5bn deal, Financial Times,weblinkweblink December 10, 2022, subscription, live, August 30, 2022, In January 2022, Joaquin Duato became CEO of Johnson & Johnson.WEB, Amanda, Macias, Berkeley Jr., Lovelace, J&J names Joaquin Duato as CEO effective Jan 3, replacing Alex Gorsky,weblink August 30, 2022, CNBC, August 19, 2021, en, In December 2022, Johnson & Johnson acquired cardiovascular medical technology company Abiomed Inc. for $16.6 billion.WEB,weblink Johnson & Johnson Completes Acquisition of Abiomed, Abiomed.com, December 22, 2022, WEB, Whooley, Sean, December 22, 2022, Johnson & Johnson completes $16.6B Abiomed acquisition,weblink December 22, 2022, MassDevice, en-US, Johnson & Johnson began the separation of their consumer healthcare business sector in November 2021.WEB, Stych, Anne, September 30, 2022, Johnson & Johnson unveils new name for planned consumer products spinoff,weblink 2023-08-29, www.bizjournals.com, In the split, Johnson & Johnson will retain the Johnson & Johnson name for prescription drugs and medical devices, while the second company will sell consumer health products and take over the Neutrogena, Aveeno, Tylenol, Listerine, Johnson's, Band-Aid and other brands.WEB, en,weblink Johnson & Johnson to split into two companies, CBS News, 2024-02-25, 2022-03-30,weblink In September 2022, Johnson & Johnson chose Kenvue as the new name for its Consumer Health business. Kenvue went public through an IPO in May 2023, with Johnson & Johnson maintaining a controlling stake of around 91 percent.WEB, Constantino, Annika Kim, 2023-05-04, J&J's consumer-health spinoff Kenvue jumps 22% in public market debut,weblink 2023-08-29, CNBC, en, On July 24, 2023, Johnson & Johnson Launched an exchange offer to split-off Kenvue.NEWS, 2023-07-24, J&J starts share exchange offer for consumer health spin-off Kenvue, en, Reuters,weblink 2023-08-29, Following the completion of the exchange offer, Johnson & Johnson will retain approximately 9.5% of the outstanding shares of Kenvue common stock.WEB, Whooley, Sean, 2023-08-23, Johnson & Johnson finalizes Kenvue spilt-off,weblink 2023-08-29, MassDevice, en-US, Johnson & Johnson holds a patent on the tuberculosis-treating drug bedaquiline, with secondary patents in at least 25 out of 43 countries with a high burden of tuberculosis blocking affordable generic versions of the drug, preventing millions of people from accessing the life-saving treatment.WEB, April 26, 2023, MSF: J&J must stop blocking generic versions of lifesaving TB drug,weblink 2023-07-13, Doctors Without Borders – USA, en, WEB, ((The Wire Staff)), 2023-03-23, J&J's Application to Extend Patent on Anti-Tuberculosis Drug Bedaquiline Rejected,weblink 2023-07-13, The Wire, Though the patent was set to expire in many countries in 2023, Johnson & Johnson applied to extend the patent. On July 13, 2023, Stop TB Partnership announced that after negotiations with Johnson & Johnson, they had been granted licenses to produce generic versions of the drug.WEB, Global Drug Facility Update on Access to Bedaquiline {{!, Stop TB Partnership |url=https://www.stoptb.org/news/global-drug-facility-update-access-to-bedaquiline |access-date=2023-09-10 |website=www.stoptb.org}}In January 2024, Johnson & Johnson announced it was acquiring Ambrx Biopharma for $2 billion.WEB, Constantino, Annika Kim, 2024-01-08, J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion,weblink 2024-01-09, CNBC, en, In April 2024, Johnson & Johnson announced it was acquiring Shockwave Medical for $13.1 billion.WEB, 2024-04-05, Johnson & Johnson boosts heart device business with $12.5 billion Shockwave Medical deal,weblink 2024-04-05, CNBC, en, WEB, 2024-04-05, Johnson & Johnson to Acquire Shockwave Medical,weblink 2024-04-10, JNJ.com, en-US, NEWS, Loftus, Colin Kellaher and Peter, Johnson & Johnson to Buy Shockwave Medical in $13.1 Billion Deal,weblink 2024-04-10, WSJ, en-US, In May, the business announced it would acquire Proteologix for $850 millionweblink Coronavirus (COVID-19) response Johnson & Johnson committed over $1 billion toward the development of a not-for-profit COVID-19 vaccine in partnership with the Biomedical Advanced Research and Development Authority (BARDA) Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS).WEB,weblink J&J collaborates to accelerate COVID-19 vaccine development, Vecchione, Anthony, March 13, 2020, NJBIZ, en-US, April 22, 2020, WEB,weblink Prisma Health collaborates with Ethicon Inc. to make, distribute VESper Ventilator Expansion Splitter Device, April 6, 2020, WSPA 7News, en-US, April 22, 2020, Paul Stoffels of Johnson & Johnson said, "In order to go fast, the people of Johnson & Johnson are committed to do this and all together we say we're going to do this not for profit. That's the fastest and the best way to find all the collaborations in the world to make this happen so we commit to bring this at a not-for-profit level."WEB,weblink Coronavirus: Johnson & Johnson vows to make 'not-for-profit' vaccine, Sky News, en, April 22, 2020, Janssen Vaccines, in partnership with Beth Israel Deaconess Medical Center (BIDMC), is responsible for developing the vaccine candidate, based on the same technology used to make its Ebola vaccine. The vaccine candidate is expected to enter phase 1 human clinical study in September 2020.WEB,weblink J&J hopes to start human trials for coronavirus vaccine in November, Stankiewicz, Kevin, March 17, 2020, CNBC, en, April 22, 2020, WEB,weblink J&J collaborates to accelerate COVID-19 vaccine development, Vecchione, Anthony, March 13, 2020, NJBIZ, en-US, April 22, 2020, Demand for the product Tylenol surged two to four times normal levels in March 2020. In response, the company increased production globally. For example, the Tylenol plant in Puerto Rico ran 24 hours a day, seven days a week.NEWS,weblink J&J's Tylenol production at maximum capacity as coronavirus boosts demand, March 19, 2020, Reuters, April 22, 2020, en, In response to the shortage of ventilators, Ethicon, with Prisma Health, made and distributed the VESper Ventilator Expansion Splitter, which uses 3D printing technology, to allow one ventilator to support two patients.WEB,weblink Prisma Health, Ethicon to Build Ventilator Split Device for Emergency Use, www.morningstar.com, en, April 22, 2020, January 22, 2021,weblink dead, Janssen COVID-19 vaccine In June 2020, Johnson & Johnson and the National Institute of Allergy and Infectious Diseases (NIAID) confirmed its intention to start a clinical trials of J&J's vaccine in September 2020, with the possibility of Phase 1/2a human clinical trials starting at an accelerated pace in the second half of July.WEB, Coleman, Justine, June 10, 2020, Final testing stage for potential coronavirus vaccine set to begin in July,weblink June 11, 2020, The Hill (newspaper), The Hill, en, NEWS, Moderna, AstraZeneca and J&J coronavirus shots rev up for NIH tests beginning in July: WSJ,weblink June 11, 2020, Fierce Pharma, June 10, 2020, en, NEWS, Johnson & Johnson to start human testing of COVID-19 vaccine next week,weblink July 20, 2020, Fierce Pharma, July 16, 2020, en, On August 5, 2020, the US government agreed to pay more than $1 billion to Johnson & Johnson (medical device company) for the production of 100 million doses of COVID-19 vaccine. As part of the agreed-upon deal, the U.S. can order up to 200 million additional doses of SARS-CoV-2 vaccine.WEB,weblink US to Pay Johnson and Johnson $1 Billion for COVID-19 Vaccine, August 5, 2020, Voice of America, August 5, 2020, In September 2020, Johnson & Johnson started its 60,000-person phase 3 adenovirus-based vaccine trial.PRESS RELEASE, Johnson, Johnson &, Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate,weblink September 24, 2020, www.prnewswire.com, en, The trial was paused on October 12, 2020, because a volunteer became ill,NEWS, Hughes, Virginia, Thomas, Katie, Zimmer, Carl, Wu, Katherine J., October 12, 2020, Johnson & Johnson halts coronavirus vaccine trial because of sick volunteer., en-US, The New York Times,weblink October 12, 2020, 0362-4331, but the company said it found no evidence that the vaccine had caused the illness and announced on October 23, 2020, that it would resume the trial.WEB, October 23, 2020, Johnson & Johnson Prepares to Resume Phase 3 ENSEMBLE Trial of its Janssen COVID-19 Vaccine Candidate in the U.S.,weblink October 28, 2020, Johnson & Johnson, en, WEB, Edwards, Erika, Miller, Sara G., October 23, 2020, AstraZeneca, Johnson & Johnson resume late-stage Covid-19 vaccine trials,weblink October 28, 2020, NBC News, en, In April 2021, the company reported that its COVID-19 vaccine achieved $100 million sales in the first quarter, accounting for less than 1% of its total revenue.WEB, Lovelace, Berkeley Jr., April 20, 2021, Johnson & Johnson reports $100 million in quarterly sales from Covid vaccine,weblink April 29, 2021, CNBC, en, NEWS, Grant, Charley, April 20, 2021, Johnson & Johnson Shows Health Economy Is Nearing Full Strength, en-US, The Wall Street Journal,weblink April 29, 2021, 0099-9660, Business sectors {{Hatnote|For specific Johnson & Johnson products, see List of Johnson & Johnson products and services}}The company's business is divided into two business sectors: Innovative Medicine and MedTech.Johnson & Johnson Innovation, LLC (JJI) is a subsidiary of Johnson & Johnson.WEB, Innovation Centers {{!, Johnson & Johnson Innovation |url=https://jnjinnovation.cohome |access-date=December 28, 2022 |website=jnjinnovation.com |language=en}} JJI focuses on early-stage, life science, and technology innovations to advance the company's research and development pipeline.WEB, Waldron, James, September 20, 2022, Johnson & Johnson opens 400-person R&D facility to strengthen Bay Area presence, https:www.fiercebiotech.com/biotech/jjs-rd-units-move-200k-sq-ft-facility-strengthen-bay-area-presence, December 28, 2022, Fierce Biotech, en, JJI provides startups with sourcing, infrastructure, and capital equipment at JLABS, financing & venture capital at JJDC, Inc., and collaborations leading to the potential development of medical device technologies, pharmaceuticals, and therapeutics.WEB, Waldron, James, September 20, 2022, Johnson & Johnson opens 400-person R&D facility to strengthen Bay Area presence,weblink December 28, 2022, Fierce Biotech, en, There are 4 JJI Innovation Centers located in London,WEB, Levin, Jennifer, March 13, 2013, Johnson & Johnson Announces Opening of London Innovation Centre,weblink December 28, 2022, Fierce Biotech, en, Shanghai, Boston (Cambridge),WEB, What If We Could Stop Lung Cancer Before It Starts?,weblink December 28, 2022, Boston University, en, and the San Francisco Bay Area. There are 13 JLABS incubators located in the Bay Area (San Francisco and South San Francisco),WEB, J&J opens new research hub near San Francisco,weblink December 28, 2022, BioPharma Dive, en-US, Belgium (Beerse), Boston (Cambridge and Lowell), Houston (TMC),WEB, Lawrence, Stacy, October 18, 2016, J&J to create new Texas center to develop 'breakthrough' med tech,weblink December 28, 2022, Fierce Biotech, en, New York City, Philadelphia, San Diego, Shanghai, Toronto, and Washington, D.C.WEB, Innovation Centers {{!, Johnson & Johnson Innovation |url=https://jnjinnovation.com//home |access-date=December 28, 2022 |website=jnjinnovation.com |language=en}}{| class="wikitable"|+Johnson & Johnson business sectors! Innovative MedicineWEB,weblink Pharmaceutical Products, Content Lab – U.S., !! MedTechWEB, MedTech,weblink Johnson & Johnson MedTech,
|Interventional solutionsOrthopaedicsSurgery (general & advanced)Vision

Innovative Medicine

The Innovative Medicine (formerly known as pharmaceuticals) segment is focused on six therapeutic areas: immunology (rheumatoid arthritis, inflammatory bowel disease and psoriasis); infectious diseases (HIV/AIDS); neuroscience (mood disorders, neurodegenerative disorders and schizophrenia); oncology (solid tumours including lung cancer, prostate cancer and bladder cancer, and hematologic malignancies); cardiovascular, metabolism, retina (thrombosis and diabetes), and pulmonary hypertension (pulmonary arterial hypertension).WEB, 0000200406-21-000008 {{!, 10-K {{!}} Johnson & Johnson |url=https://johnsonandjohnson.gcs-web.com/sec-filings/sec-filing/10-k/0000200406-21-000008/ |access-date=February 23, 2021 |website=johnsonandjohnson.gcs-web.com |language=en}}

MedTech

The Cardiovascular & Specialty Solutions Group includes electrophysiology products that diagnose and treat cardiac arrhythmias; devices used in the endovascular treatment of hemorrhagic and ischemic stroke; solutions that focus on breast reconstruction and aesthetics, and ear, nose and throat procedures.NEWS, December 1, 2008, J&J to buy breast implant firm Mentor for $1.1 billion, en, Reuters,weblink September 28, 2021, The orthopaedics portfolio is composed of specialties including joint reconstruction, trauma, extremities, craniomaxillofacial, spinal surgery and sports medicine, in addition to the VELY digital surgery portfolio.WEB, DePuy Synthes Product, Inc. Leases Palm Beach Gardens Office Space Expanding South Florida Footprint,weblink September 28, 2021, PROFILE Miami, September 8, 2021, en-US, The surgery portfolio includes advanced surgical innovations and solutions such as sutures, staplers, energy devices, and advanced hemostats along with interventional ablation, surgical robotics, and digital solutions.WEB, January 10, 2016, ETHICON History,weblink September 28, 2021,weblink" title="web.archive.org/web/20160110154950weblink">weblink January 10, 2016, The Johnson & Johnson Vision portfolio includes contact lens, intraocular lens, automated treatment for dry eye, and four brands of laser vision correction systems.TITLEJOHNSON & JOHNSON: SHAREHOLDERS BOARD MEMBERS MANAGERS AND COMPANY PROFILE {{!, US4781601046 {{!}} MarketScreener |urweblink |access-date2024-03-24 |websitewww.marketscreener.com |languageen}}">

Finance {| class"wikitable floatright"TITLEJOHNSON & JOHNSON: SHAREHOLDERS BOARD MEMBERS MANAGERS AND COMPANY PROFILE {{!, US4781601046 {{!}} MarketScreener |urweblink |access-date2024-03-24 |websitewww.marketscreener.com |languageen}}

!Region!share|United States|54.5%|Europe|24.0%|Asia-Pacific, Africa|16.2%|Western Hemisphere (without US)|5.2%For the fiscal year 2022, Johnson & Johnson reported earnings of $17.9 billion, with an annual revenue of $94.94 billion, an increase of 1.25% over the previous fiscal cycle. Johnson & Johnson's shares traded at over $175 per share, and its market capitalization was valued at over $439.8{{nbs}}billion in September 2022.WEB, Johnson & Johnson Revenue 2010–2022 {{!, JNJ |url=https://www.macrotrends.net/stocks/charts/JNJ/johnson-johnson/revenue |access-date=January 29, 2023 |website=www.macrotrends.net}}{| class="wikitable float-left" style="text-align: right;"!Year!Revenuein million US$!Net incomein million US$!EmployeesWEB,weblink Johnson & Johnson – Mitarbeiter bis 2017 {{!, Statistik|website=Statista|language=de|access-date=December 9, 2018}}|2005|50,514|10,060|115,600|2006|53,324|11,053|122,200|2007|61,095|10,576|119,200|2008|63,747|12,949|118,700|2009|61,897|12,266|115,500|2010|61,587|13,334|114,000|2011|65,030|9,672|117,900|2012|67,224|10,853|127,600|2013|71,312|13,831|128,100|2014|74,331|16,323|126,500|2015|70,074|15,409|127,100|2016|71,890|16,540|126,400|2017|76,450|1,300|155,000|2018|81,581|15,297|134,000|2019|82,059|15,119|132,200|2020|82,584|14,714|134,500|2021|93,775|20,878|141,700|2022|94,943|17,941|155,800

Corporate governance

As of 2023, the members of the board of directors of Johnson & Johnson are Joaquin Duato, Darius Adamczyk, Mary C. Beckerle, D. Scott Davis, Jennifer A. Doudna, Marillyn A. Hewson, Paula A. Johnson, Hubert Joly, Mark B. McClellan, Anne M. Mulcahy, Mark A. Weinberger, Nadja Y. West, and Eugene A. Woods.WEB, Our Leadership Team,weblink 2023-06-22, Content Lab U.S., en, As of 2023, the members of the executive committee of Johnson & Johnson are Joaquin Duato, Vanessa Broadhurst, Peter Fasolo, Liz Forminard, William N. Hait, Tim Schmid, John C. Reed, James Swanson, Jennifer Taubert, Kathy E. Wengel, and Joseph J. Wolk.WEB, Our Leadership Team,weblink 2023-06-22, Content Lab U.S., en, Joaquin Duato is chairman and chief executive officer.WEB, Rivas, Kayla, August 20, 2021, J&J's new CEO Joaquin Duato: What to know,weblink April 12, 2022, FOXBusiness, en-US, WEB, Joaquin Duato to Take Over as Chief Executive Officer of Johnson & Johnson,weblink April 12, 2022, New Jersey Business Magazine, en-US,

Chairmen

• Robert Wood Johnson I (1887–1910)
• James Wood Johnson (1910–1932)
• Robert Wood Johnson II (1932–1963)
• Philip B. Hofmann (1963–1973)
• Richard B. Sellars (1973–1976)
• James E. Burke (1976–1989)
• Ralph S. Larsen (1989–2002)
• William C. Weldon (2002–2012)
• Alex Gorsky (2012–2022)
• Joaquin Duato (2023–present)WEB, Johnson & Johnson CEO Joaquin Duato to take additional role of chairman,weblink December 28, 2022, CNBC, December 2022, en,

Ownership

Johnson & Johnson is mainly owned by institutional investors, with over 70% of shares held. The 10 largest shareholder of Johnson & Johnson in December 2023 were:WEB, Johnson & Johnson (JNJ) Stock Major Holders - Yahoo Finance,weblink 2024-03-08, finance.yahoo.com, en-US,

• The Vanguard Group (9.52%)
• BlackRock (7.73%)
• State Street Corporation (5.52%)
• Geode Capital Management (2.13%)
• Morgan Stanley (1.73%)
• State Farm (1.32%)
• JPMorgan Chase (1.24%)
• Northern Trust (1.23%)
• Capital International Investors (1.20%)
• Norges Bank (1.08%)

Environmental record

Johnson & Johnson has set several positive goals to keep the company environmentally friendly and was ranked third among the United States's largest companies in Newsweek{{'}}s "Green Rankings".WEB,weblink Green Rankings, dead,weblink" title="web.archive.org/web/20091010035720weblink">weblink, October 10, 2009, Some examples are the reduction in water use, waste, and energy use and an increased level of transparency.WEB, http:www.jnj.com/connect/caring/environment-protection/environment-performance/, Johnson & Johnson Official Site, May 4, 2008, dead,weblink" title="web.archive.org/web/20080502231556weblink">weblink May 2, 2008, Johnson & Johnson agreed to change its packaging of plastic bottles used in the manufacturing process, switching their packaging of liquids to non-polyvinyl chloride containers.Environment New Service, December 8, 2004. Retrieved May 4, 2008 The corporation is working with the Climate Northwest Initiative and the EPA National Environmental Performance Track program.WEB,weblink Coop America, March 27, 2008, May 4, 2008,weblink" title="web.archive.org/web/20080426010045weblink">weblink April 26, 2008, dead, As a member of the national Green Power Partnership, Johnson & Johnson operates the largest solar power generator in Pennsylvania at its site in Fort Washington, Pennsylvania.WEB,weblink Department of Environmental Protection, Commonwealth of Pennsylvania,

Recalls and litigation

1982 Chicago Tylenol murders

On September 29, 1982, a "Tylenol scare" began when the first of seven individuals died in Chicago metropolitan area, after ingesting Extra Strength Tylenol that had been deliberately laced with cyanide. Within a week, the company pulled 31 million bottles of capsules back from retailers, making it one of the first major recalls in American history.NEWS, The New York Times,weblink Tylenol made a hero of Johnson & Johnson : The recall that started them all, March 23, 2002, Judith Rehak, The incident led to reforms in the packaging of over-the-counter substances and to federal anti-tampering laws. The case remains unsolved and no suspects have been charged. Johnson & Johnson's quick response, including a nationwide recall, was widely praised by public relations experts and the media and was the gold standard for corporate crisis management.Toyota, what's so hard about doing the right thing?, Los Angeles Times, February 11, 2010Jennifer Latson for Time Magazine September 29, 2014 How Poisoned Tylenol Became a Crisis-Management Teaching ModelJudith Rehak for The New York Times. March 23, 2002 Tylenol made a hero of Johnson & Johnson : The recall that started them all

2010 children's product recall

On April 30, 2010, McNeil Consumer Healthcare, a subsidiary of Johnson & Johnson, voluntarily recalled 43 over-the-counter children's medicines, including Tylenol, Tylenol Plus, Motrin, Zyrtec and Benadryl. The recall was conducted after a routine inspection at a manufacturing facility in Fort Washington, Pennsylvania, United States, revealed that some "products may not fully meet the required manufacturing specifications". Affected products may contain a "higher concentration of active ingredients" or exhibit other manufacturing defects.NEWS, Watts A, Warning As Baby Medicines Are Recalled,weblink Sky News, May 2, 2010, May 3, 2010, Products shipped to Canada, Dominican Republic, Mexico, Guam, Guatemala, Jamaica, Puerto Rico, Panama, Trinidad and Tobago, the United Arab Emirates, Kuwait and Fiji were included in the recall. In a statement, Johnson & Johnson said "a comprehensive quality assessment across its manufacturing operations" was underway.US FIRM RECALLS CHILDREN'S DRUGS >URL=HTTP://ENGLISH.ALJAZEERA.NET/NEWS/AMERICAS/2010/05/2010518535960539.HTML AL JAZEERA ARABIC>AL JAZEERAACCESS-DATE=MAY 3, 2010, A dedicated website was established by the company listing affected products and other consumer information.

2010 hip-replacement recall

On August 24, 2010, DePuy, a subsidiary of American giant Johnson & Johnson, recalled its ASR (articular surface replacement) hip prostheses from the market. DePuy said the recall was due to unpublished National Joint Registry data showing a 12% revision rate for resurfacing at five years and an ASR XL revision rate of 13%. All hip prostheses fail in some patients, but it is expected that the rate will be about 1% a year.NEWS,weblink Out of joint: The story of the ASR, May 14, 2011, Deborah Cohen, Pathologically, the failing prosthesis had several effects. Metal debris from wear of the implant led to a reaction that destroyed the soft tissues surrounding the joint, leaving some patients with long term disability. Ions of cobalt and chromium{{snd}}the metals from which the implant was made{{snd}}were also released into the blood and cerebral spinal fluid in some patients.NEWS,weblink FDA. Concerns about metal-on-metal hip implant systems. 2011, 2011, In March 2013, a jury in Los Angeles ordered Johnson & Johnson to pay more than $8.3{{nbs}}million in damages to a Montana man in the first of more than 10,000 lawsuits pending against the company in connection with the now-recalled DePuy hip.NEWS, Meier B, J.&J. Loses First Case Over Faulty Hip Implant,weblink September 4, 2013, The New York Times, March 8, 2013, Some lawyers and industry analysts have estimated that the suits ultimately will cost Johnson & Johnson billions of dollars to resolve.

2010 Tylenol recall

In 2010 and 2011, Johnson & Johnson voluntarily recalled some over-the-counter products, including Tylenol, due to an odor caused by tribromoanisole.Tylenol Recall Expands, WebMD Health News, January 18, 2010WEB,weblink McNeil Consumer Healthcare Announces Voluntary Recall Of One Product Lot Of TYLENOL® Extra Strength Caplets 225 Count Distributed In The U.S., Food and Drug Administration, In this case, 2,4,6-tribromophenol was used to treat wooden pallets on which product packaging materials were transported and stored.

Shareholders lawsuit

In 2010 a group of shareholders sued the board for allegedly failing to take action to prevent serious failings and illegalities since the 1990s, including manufacturing problems, bribing officials, covering up adverse effects and misleading marketing for unapproved uses. The judge initially dismissed the case in September 2011, but allowed the plaintiffs opportunity to refile at a later time.WEB,weblink 10-cv-2033, D. NJ., Sept. 29, 2011, In 2012 Johnson and Johnson proposed a settlement with the shareholders, whereby the company would institute new oversight, quality and compliance procedures binding for five years.J&J, shareholders reach tentative deal in lawsuit By Linda A. Johnson, AP Business Writer / July 12, 2012

Illegal marketing of Risperdal

Juries in several US states have found J&J guilty of concealing the adverse effects of Janssen Pharmaceuticals' antipsychotic medication Risperdal, produced by its unit, to promote it to doctors and patients as better than cheaper generics, and of falsely marketing it for treating patients with dementia.WEB,weblink Johnson & Johnson to pay $2 billion for false marketing, November 4, 2013, CNN Money, Gregory Wallace, November 6, 2013, States that have awarded damages include Texas ($158{{nbs}}million), South Carolina ($327{{nbs}}million), Louisiana ($258{{nbs}}million), and most notably Arkansas ($1.2{{nbs}}billion).J.&J. Fined $1.2{{nbs}}Billion in Drug Case NY Times, By KATIE THOMAS Published: April 11, 2012In 2010, the United States Department of Justice joined a whistleblowers suit accusing the company of illegally marketing Risperdal through Omnicare, the largest company supplying pharmaceuticals to nursing homes.NEWS, Hilzenrath, David S., January 16, 2010, Justice suit accuses Johnson & Johnson of paying kickbacks,weblink The Washington Post, January 17, 2010, NEWS, Singer, Natasha, January 15, 2010, Johnson & Johnson Accused of Drug Kickbacks,weblink The New York Times, January 17, 2010, The allegations include that J&J were warned by the FDA to not promote Risperdal as effective and safe for elderly patients, but they did so, and that they paid Omnicare to promote the drug to care home physicians.J&J Said to Agree to $2.2{{nbs}}Billion Drug Marketing Accord Bloomberg News. By Margaret Cronin Fisk, Jef Feeley & David Voreacos{{snd}}June 11, 2012 The settlement was finalized on November 4, 2013, with J&J agreeing to pay a penalty of around $2.2{{nbs}}billion, "including criminal fines and forfeiture totaling $485{{nbs}}million and civil settlements with the federal government and states totaling $1.72{{nbs}}billion".WEB, Office of Public Affairs, Department of Justice, Johnson & Johnson to Pay More Than $2.2 Billion to Resolve Criminal and Civil Investigations,weblink United States Department of Justice, June 16, 2015, November 4, 2015, Johnson & Johnson has also been subject to congressional investigations related to payments given to psychiatrists to promote its products and ghost write articles, notably Joseph Biederman and his pediatric bipolar disorder research unit.Research Center Tied to Drug Company By Gardiner Harris, The New York Times, 2008

Foreign bribery

In 2011, J&J settled litigation brought by the US Securities and Exchange Commission under the Foreign Corrupt Practices Act and paid around $70M in disgorgement and fines.WEB,weblink Johnson & Johnson, www.sec.gov, en, July 5, 2017, J&J's employees had given kickbacks and bribes to doctors in Greece, Poland, and Romania to obtain business selling drugs and medical devices and had bribed officials in Iraq to win contracts under the Oil for Food program.NEWS,weblink J&J settles U.S., UK bribery, kickback charges, April 8, 2011, Reuters, July 5, 2017, J&J fully cooperated with the investigation once the problems came to light.NEWS, SEC Charges Johnson & Johnson With Foreign Bribery,weblink SEC, April 7, 2011,

Consumer fraud settlements

In May 2017, J&J reached an agreement to pay $33{{nbs}}million to several states to settle consumer fraud allegations in some of the company's over-the-counter drugs.WEB,weblink J&J Reaches $33 Million Settlement with States, DrugWatch, July 5, 2017, NEWS,weblink Johnson & Johnson settles drug manufacturing probe by US states for $33 million, Reuters, May 24, 2017, The Economic Times, India, July 5, 2017, {{Dead link|date=July 2018 |bot=InternetArchiveBot |fix-attempted=yes }}NEWS,weblink UPDATE 1-J&J settles drug manufacturing probe by U.S. states for $33 mln, Business Insider, July 5, 2017, en, April 12, 2019,weblink dead,

Use of the Red Cross symbol

{{Further|Emblems of the International Red Cross and Red Crescent Movement#Use of the emblems}}File:Flag of the Red Cross.svg|thumb|150px|Flag of the Red CrossRed CrossJohnson & Johnson registered the Red Cross as a U.S. trademark for "medicinal and surgical plasters" in 1905 and has used the design since 1887.WEB,weblink Trademark Status & Document Retrieval, uspto.gov, The Geneva Conventions, which reserved the Red Cross emblem for specific uses, were first approved in 1864 and ratified by the United States in 1882. However, the emblem was not protected by U.S. law for the use of the American Red Cross (ARC) and the U.S. military until after Johnson & Johnson had obtained its trademark. A clause in this law (now 18 U.S.C. 706) permits this pre-existing use of the Red Cross to continue.WEB, 1205.01 Statutory Protection,weblink April 26, 2023, tmep.uspto.gov, JOURNAL, Sturges, Wesley, 1957, The Legal Status of the Red Cross,weblink Michigan Law Review, 56, 1, 24–25, 10.2307/1285901, 1285901, Michigan Law Scholarship Repository, WEB, § 706. Red Cross,weblink April 26, 2023, GovRegs, A declaration made by the U.S. upon its ratification of the 1949 Geneva Conventions includes a reservation that pre-1905 U.S. domestic uses of the Red Cross, such as Johnson & Johnson's, would remain lawful as long as the cross is not used on "aircraft, vessels, vehicles, buildings or other structures, or upon the ground", i.e., uses which could be confused with its military uses.U.S. reservations to the 1949 Geneva Conventions (International Committee of the Red Cross website) This means that the U.S. did not agree to any interpretation of the 1949 Geneva Conventions that would overrule Johnson & Johnson's trademark. The American Red Cross continues to recognize the validity of Johnson & Johnson's trademark.American Red Cross Defends Use of Emblem and Mission {{Webarchive|url=https://web.archive.org/web/20070818044717weblink |date=August 18, 2007 }} (American Red Cross press release, August 10, 2007)In August 2007, Johnson & Johnson filed a lawsuit against the ARC, demanding that the charity halt the use of the red cross symbol on products it sells to the public, though the company takes no issue with the charity's use of the mark for nonprofit purposes."Red Cross Is Sued by J&J Over Signature Emblem" The Wall Street Journal August 9, 2007 In May 2008, the judge in the case dismissed most of Johnson & Johnson's claims, and a month later the two organizations announced a settlement had been reached in which both parties would continue to use the symbol.NEWS,weblink Claim Over Red Cross Symbol Is Settled, The New York Times, June 18, 2008, Saul S, Stephanie Saul,

Boston Scientific lawsuits

Since 2003, Johnson & Johnson and Boston Scientific have both claimed that the other had infringed on their patents covering heart stent medical devices. The litigation was settled when Boston Scientific agreed to pay $716{{nbs}}million to Johnson & Johnson in September 2009 and an additional $1.73{{nbs}}billion in February 2010.Boston Scientific to Pay J&J $1.73B to Settle Stent Patent Disputes, The Wall Street Journal, February 2, 2010 Their dispute was renewed in 2014, now on the grounds of a contract dispute.J&J seeks over $5{{nbs}}billion in damages from Boston Scientific at trial. Reuters, November 19, 2014

Patent-infringement case against Abbott

In 2007, Johnson & Johnson sued Abbott Laboratories over the development and sale of the arthritis drug Humira, claiming Abbott used technology licensed exclusively to Johnson & Johnson's Centocor division. Johnson & Johnson won the court case, and in 2009 Abbott was ordered to pay Johnson & Johnson $1.17{{nbs}}billion in lost revenues and $504{{nbs}}million in royalties.Abbott Told to Pay Record $1.67{{nbs}}billion Award to J&J, Bloomberg News, June 29, 2009 The judge also added $175.6{{nbs}}million in interest to bring the total to $1.84{{nbs}}billion.Abbott Challenges $1.67{{nbs}}billion Patent Loss to J&J Over Humira, Bloomberg News, November 2, 2010 This was the largest patent-infringement award in U.S. history until the 2013 decision against Teva in favor of Takeda and Pfizer for over $2.1{{nbs}}billion.Pfizer, Takeda to Get $2.15{{nbs}}Billion Settlement, WSJ, December 6, 2013 In 2010 Abbott appealed the verdict and in 2011 won the appeal.WEB,weblink abbott-wins-reversal-of-j-j-s-1-67-billion-patent-victory, Bloomberg News, Bloomberg, dead,weblink" title="web.archive.org/web/20110506001424weblink">weblink May 6, 2011,

Vaginal mesh implants

Tens of thousands of women worldwide have taken legal action against Johnson & Johnson after suffering serious complications following a vaginal mesh implant procedure.WEB,weblink States file lawsuit against Johnson & Johnson over pelvic mesh implants, www.cbsnews.com, May 25, 2016, In Australia, more than 700 women began a class action against the company in the Federal Court of Australia in 2017, telling the court they "suffered irreparable, debilitating pain after the devices began to erode into surrounding tissue and organs, causing infections and complications". The class action alleged that Johnson & Johnson, which "aggressively marketed" the implants "failed to properly warn patients and surgeons of the risk, or test the devices adequately".WEB,weblink Vaginal mesh risks downplayed by Johnson & Johnson, court told, Knaus C, July 4, 2017, The Guardian, Emails between executives show the company was aware of the risks in 2005 but still went ahead and made the product available.NEWS,weblink Pharma giant sold mesh implant despite pain warnings, Devlin H, November 27, 2018, The Guardian, November 25, 2019, en-GB, 0261-3077, In November 2019 the Federal Court of Australia found Johnson & Johnson negligent.WEB, September 12, 2022, Johnson & Johnson to pay pelvic mesh victims record $300m settlement,weblink December 5, 2022, Australian Financial Review, en, The judgment was appealed, with the appeals court upholding all findings of Justice Anna Katzman.WEB, King, Madar, Wood Mallesons-Suzy, McDonnell, Justin, Saville, Moira, Stevenson, Peta, Swinn, Matthew, March 9, 2021, Appeal in Ethicon pelvic mesh class action – what risks need to be disclosed?,weblink December 5, 2022, Lexology, en, Ethicon then sought a High Court decision but this was not permitted by the High Court of Australia. Subsequently (September 2022) a A$300,000,000 compensation agreement was reached between Shine Lawyers and J&J but this agreement remains subject to approval by the Federal Court of Australia.In the US in 2016 the U.S. states of California and Washington filed a lawsuit against the company, accusing it of deception. In October 2019, the company and its subsidiary, Ethicon, Inc. reached a settlement with 41 states and the District of Columbia, with no admission of liability, in a suit alleging deceptive marketing of transvaginal surgical-mesh devices. The suit also alleges that the company failed to disclose risks associated with the product, which J&J pulled from the US market in 2012. The amount settled in the suit was about $117{{nbs}}million.NEWS, Sebastian D, Johnson & Johnson to Pay $117{{nbs, Million Over Surgical Device Marketing |url=https://www.wsj.com/articles/johnson-johnson-to-pay-117-million-over-surgical-device-marketing-11571334613 |work=The Wall Street Journal |publisher=Dow Jones and Company |date=October 17, 2019 |location=New York NY}}

Baby powder

J&J has been the subject of over 26,000 lawsuits claiming that its baby powder causes ovarian cancer. The lawsuits focus on claims that the talc-based powder is contaminated with asbestos, a known carcinogen commonly found in places where talc is mined.NEWS, Stohr, Greg, Feeley, Jef, June 1, 2021, J&J to Pay $2.1 Billion Talc Award as Top Court Nixes Appeal, Bloomberg News,weblink June 1, 2021, In 2016, J&J was ordered to pay $72{{nbs}}million in damages to the family of Jacqueline Fox, a 62-year-old woman who died of ovarian cancer in 2015. The company said it would appeal.NEWS, Johnson & Johnson hit with $72m damages in talc-cancer case,weblink February 24, 2016, BBC News, February 24, 2016, A year later, over 1,000 U.S. women had sued J&J for covering up the possible cancer risk from its Baby Powder product. The company says that 70% of its Baby Powder is used by adults.Johnson & Johnson Has a Baby Powder Problem Bloomberg, Retrieved April 20, 2017. Later that year, a California jury ordered Johnson & Johnson to pay $417{{nbs}}million to a woman who claimed she developed ovarian cancer after using the company's talc-based products like Johnson's Baby Powder for feminine hygiene. The verdict included $70{{nbs}}million in compensatory damages and $347{{nbs}}million in punitive damages. J&J said they would appeal the verdict.NEWS,weblink J&J ordered to pay $417{{nbs, million in trial over talc cancer risks|date=August 21, 2017|newspaper=Reuters|last1=Raymond|first1=Nate}} The Missouri Eastern District appeals court later negated a $72{{nbs}}million jury verdict in the Jacqueline Fox lawsuit, ruling it lacked jurisdiction in Missouri because of a U.S. Supreme Court decision that imposed limits on where injury lawsuit can be filed. Subsequently, this ruling killed three other recent St. Louis jury verdicts of more than $200{{nbs}}million combined. Fox, 62, of Birmingham, Alabama, died in 2015, about four months before her trial was held in St. Louis Circuit Court. She was among 65 plaintiffs, of whom only two were from Missouri.WEB,weblink Missouri appeals court tosses out $72 million Johnson & Johnson talcum powder verdict, Currier J, October 17, 2017, A St. Louis jury awarded nearly $4.7{{nbs}}billion in damages to 22 women and their families in 2018 after they claimed that asbestos in Johnson & Johnson talcum powder caused their ovarian cancer.NEWS, Bever L, Johnson & Johnson ordered to pay $4.7 billion to women who say baby powder gave them cancer,weblink The Washington Post, July 28, 2018, en, July 13, 2018, In August, J&J said that it removed several chemicals from baby powder products and re-engineered them to make consumers more confident that products were safer for children.WEB,weblink Johnson and Johnson removes chemicals to make products safer, August 7, 2018, August 25, 2018, The company was forced to release internal documents with 11,700 people suing J&J over cancers allegedly caused by baby powder. The documents showed that the company had known about asbestos contamination since at least as early as 1971 and had spent decades finding ways to conceal the evidence from the public.WEB,weblink Johnson & Johnson knew for decades that asbestos lurked in some of its baby powder, NBC News, December 14, 2018, The company lost its request to reverse a jury verdict that ruled in favor of the accusers, which required the company to pay $4.14{{nbs}}billion in punitive damages and $550{{nbs}}million in compensatory damages.WEB,weblink J&J loses its battle to overturn a $4.7B baby powder verdict, Scipioni J, December 19, 2018, FOXBusiness, en-US, December 19, 2018, A large study performed in 2003 found that ovarian cancer risk increased from a baseline of 0.0121% to 0.0161% in people who reported regularly using talc in the genital area. Two more studies over the next twelve years, which also relied on self-reporting, had similar results; however, none of the three studies showed a relationship between how long someone used talc and how much their cancer risk increased, which is expected in experiments with carcinogens and other toxic substances (see dose–response relationship).WEB,weblink The Johnson and Johnson Talc Cancer Case, Steven Novella, Neurologica blog, February 25, 2016, September 30, 2019, Steven Novella, Conversely, a St. Louis jury ruled in favor of Johnson & Johnson in the case of a single plaintiff who had used the company's talc-containing baby powder for thirty years with a similar claim.NEWS,weblink St. Louis jury sides with Johnson & Johnson in talc case, Salter J, December 23, 2019, The Seattle Times, December 24, 2019, Associated Press, The company's CEO, Alex Gorsky, declined to appear at a United States congressional hearing on the safety of J&J's Baby Powder and other talc-based cosmetics. J&J spokesman Ernie Knewitz said that the subcommittee had rejected the company's offers to send a talc testing expert or a J&J executive in charge of consumer products.WEB,weblink Johnson & Johnson CEO refuses to attend US hearing on carcinogens, December 10, 2019, www.aljazeera.com, December 11, 2019, In response to declining demand, J&J announced it would discontinue the sale of talc-based baby powder in the United States and Canada in 2020, but would continue to sell it in other markets. In a statement, the company said that the existing retail inventory of the talc-based powder will sell until it runs out, while the company's cornstarch-based baby powder will continue to sell in the United States and Canada.WEB, Johnson & Johnson to discontinue sales of talc-based baby powder in U.S., Canada,weblink Albert V, May 19, 2020, CBS News, en-US, May 19, 2020, The Supreme Court of Missouri refused to consider J&J's appeal of a $2.12 billion damages award to women who blamed their ovarian cancer on its talc-based products.WEB,weblink Johnson & Johnson fails to overturn $2.12 billion baby powder verdict, plans Supreme Court appeal, Reuters, November 3, 2020, Jonathan Stempel, March 24, 2022, WEB,weblink Women With Cancer Awarded Billions in Baby Powder Suit, The New York Times, June 23, 2020, Roni Caryn Rabin, March 24, 2022, The Supreme Court of the United States also refused to consider an appeal from J&J, leaving in place a judgment from a state appeal court that had cut the original award to $2.1 billion.WEB,weblink Supreme Court won't review $2 billion verdict against Johnson & Johnson in talc powder case, CNN, June 1, 2021, Ariane de Vogue, Jen Christensen, March 24, 2022, Two of the justices had to recuse: Samuel Alito because either he and/or his wife owning or recently owning stock in J&J, and Brett Kavanaugh, whose father led an industry group lobbying against safety warnings on talc products. Representing the affected women during the trial, Mark Lanier remarked that the Supreme Court's decision sent "a clear message to the rich and powerful: You will be held to account when you cause grievous harm under our system of equal justice under law."WEB, Supreme Court Won't Consider Johnson & Johnson Challenge to Baby Powder Judgment,weblink Brent Kendall, Peter Loftus, June 1, 2021, The Wall Street Journal, en-US, June 11, 2021, WEB, Supreme Court Says A $2 Billion Verdict In A Baby Powder Cancer Case Should Remain,weblink June 1, 2021, NPR, en-US, June 11, 2021, J&J had argued that the combined claims in the St. Louis trial were too different, yet the short jury deliberation and identical payouts were, therefore, a violation of the company's due process and also that the high punitive award was unconstitutional.In 2021, Johnson & Johnson subsidiary LTL Management LLC, using a process called a Texas divisional merger, filed for Chapter 11 bankruptcy in North Carolina. The process allowed by Texas law lets a company create a separate subsidiary to take over liabilities, with the existing company operating normally. The new company, with a different name, can locate in a state such as North Carolina where bankruptcy laws are different, and then declare bankruptcy, paying less than the original company would have. In the case of LTL, a $2 billion trust will be created, compared to $25 billion if Johnson & Johnson had declared bankruptcy. According to the filing, a company known as Old JJCI took on the baby powder related liabilities in 1979, while Johnson & Johnson remained a defendant. LTL and New JJCI were created with LTL taking the baby powder related liabilities and some assets, and New JJCI taking the remaining assets. Johnson & Johnson says LTL is now based in New Jersey.NEWS,weblink Johnson & Johnson forms new subsidiary to take ovarian cancer claims into bankruptcy court, Walters, Natalie, The Dallas Morning News, October 14, 2021, October 16, 2021, NEWS, J&J is using a bankruptcy maneuver to block lawsuits over baby powder cancer claims, en, NPR,weblink October 22, 2021, The company announced that it would stop making talc-based powder by 2023 and replace it with cornstarch-based powders. The company says the talc-based powder is safe to use and does not contain asbestos.NEWS,weblink J&J to replace talc-based powder with cornstarch after cancer lawsuits, August 12, 2022, BBC News, August 12, 2022, In 2023, the number of lawsuits regarding talc-based baby powder has exceeded 40,000 as more claimants come forward to say that the company's product caused them to have cancer. Johnson & Johnson have now reportedly offered $9 billion to settle all the lawsuits against the company, up from the previous figure of $2 billion.NEWS,weblink Johnson & Johnson offers $9bn to settle talc claims, April 5, 2023, BBC News, April 5, 2023,

Opioid epidemic

{{Further|Opioid epidemic in the United States}}By 2018, the company had become embroiled in the opioid epidemic in the United States and had become a target of lawsuits.NEWS,weblink DOJ to Support Lawsuits Against Companies Selling Opioids, Gurman S, Mulvihill G, March 2, 2018, Drug Discovery & Development, March 2, 2018, Advantage Business Media, Associated Press, NEWS,weblink Johnson & Johnson acted as opioid kingpin, Oklahoma attorney general says, March 12, 2019, March 14, 2019, CNN, Over 500 opioid-related cases have been filed as of May 2018 against J&J and its competitors.WEB,weblink Trump Insurance For Johnson & Johnson, August 17, 2018, August 25, 2018, In Idaho, J&J is part of a lawsuit accusing the company for being partially to blame for opioid-related overdose deaths.WEB,weblink 11 Idaho counties take on Walmart, CVS, drug companies in opioid lawsuit, August 25, 2018, The first major trial began in Oklahoma in May 2019.NEWS,weblink First Big Trial in Opioid Crisis Set to Kick Off in Oklahoma, Randazzo S, May 27, 2019, The Wall Street Journal, May 28, 2019, en-US, 0099-9660, On August 26, 2019, the Oklahoma judge ordered J&J to pay $572{{nbs}}million for their part in the opioid crisis,WEB,weblink Oklahoma wins case against drugmaker in historic opioid trial, CNN, Howard J, Drash W, August 26, 2019, August 26, 2019, and in October J&J paid $20.4{{nbs}}million to two Ohio counties fighting the opioid epidemic.WEB,weblink Johnson & Johnson to Pay Ohio Counties $20.4M Opioid Settlement, www.usnews.com, In January 2022, Johnson & Johnson agreed to pay up to $5 billion as part of a $26 billion settlement which included McKesson, AmerisourceBergen, and Cardinal Health.NEWS, Raymond, Nate, January 27, 2022, Most U.S. local governments opt to join $26 bln opioid settlement, en, Reuters,weblink February 21, 2022, Had the states gone to court, the companies could have faced up to $95 billion in penalties.NEWS, Raymond, Nate, November 16, 2021, Washington state, in $95 billion opioid trial, blames drug distributors for crisis, en, Reuters,weblink February 21, 2022,

Northeastern Ohio Settlement

In October 2019, the company agreed to a settlement of $20.4{{nbs}}million with two Ohio counties{{snd}}Cuyahoga (Cleveland) and Summit (Akron). The settlement allows the company avoidance of a trial accusing J&J and many other pharmaceutical manufacturers of helping to spark the US opioid epidemic. The trial was thought to be an indicator for thousands of opioid-related lawsuits against many drug manufacturers. The arrangement, which contains no admission of liability by the company, provides the counties $10{{nbs}}million in cash, $5{{nbs}}million for legal expenses and $5.4{{nbs}}million in contributions to opioid-related nonprofit organizations in the counties.NEWS, Randazzo S, Johnson & Johnson Agrees to Settle Ohio Opioid Lawsuits for $20.4 Million,weblink The Wall Street Journal, Dow Jones and Company, October 1, 2019, New York NY,

Public-private engagement

Johnson & Johnson and its subsidiaries engage with the public and private sectors in a variety of settings including to promote research and development, academic funding, event sponsorship, philanthropy, and political lobbying.

Academia

• J&J is a matching gift donor to the Institute for Advanced Study.WEB, Simonyi, Charles, Dijkgraaf, Robbert, 2018, Report for the Academic Year 2017–2018,weblink live,weblink May 31, 2022, August 2, 2022, Institute for Advanced Study,

Activism

• J&J is a corporate partner of Human Rights Campaign, a large LGBT advocacy group.WEB, Corporate Partners,weblink live,weblink July 14, 2022, July 14, 2022, Human Rights Campaign, en-US,
• J&J is a financial supporter of Women Deliver.WEB, Boyle, Kelsi, Our Supporters,weblink live,weblink July 19, 2022, July 19, 2022, Women Deliver, en-US,

Political lobbying

Johnson & Johnson is engaged in various forms of lobbying in the United States, Canada and internationally, including through corporate philanthropy and membership in lobbying organizations.

• J&J is one of the largest donors to the Foundation for the National Institutes of Health (FNIH), having donated $5–10 million from 2000 to 2020.WEB, 2020 Donors,weblink live,weblink April 2, 2022, April 6, 2022, FNIH 2020 Annual Report, en,
• J&J is a partner of the Pandemic Action Network.WEB, Our Network,weblinkwww.pandemicactionnetwork.org/our-network/, live, https:web.archive.org/web/20220724022128weblink July 24, 2022, July 24, 2022, Pandemic Action Network, en,
• J&J is a member company of the Biotechnology Innovation Organization (BIO) and the Pharmaceutical Research and Manufacturers of America (PhRMA), trade associations that lobby the U.S. Government on behalf of the Biotechnology Industry and pharmaceutical industry.WEB, About,weblink live,weblink April 6, 2022, April 6, 2022, PhRMA, WEB, Johnson & Johnson {{!, BIO |url=https://www.bio.org/policy/human-health/vaccines-biodefense/coronavirus/johnson-johnson |access-date=2024-04-14 |website=www.bio.org |language=en}} BIO and PhRMA have offices in Washington, D.C., with PhRMA also having locations in Japan and the United Arab Emirates.
• J&J is a member of the Personalized Medicine Coalition, a medical research advocacy group that lobbies on behalf of the pharmaceutical industry to increase funding for personalized medicine research and development.WEB, Current Members,weblink live,weblink August 15, 2021, April 6, 2022, Personalized Medicine Coalition, en,
• J&J is a member company of the National Pharmaceutical Council (NPC), a nonprofit that advocates for expanded research funding and innovation.WEB, Members,weblink live,weblink April 7, 2022, April 7, 2022, National Pharmaceutical Council, en,

Research and development

J&J has provided research grants and major funding to the C. D. Howe Institute.WEB, C. D. Howe Institute, Annual Report 2019,weblink live,weblink June 8, 2020, June 8, 2021,

See also

• Zodiac (schooner)

References

{{Reflist}}

External links

{{Commons category}}

• {{Official websiteweblink}}

{{Finance links| name = Johnson & Johnson| symbol = JNJ| sec_cik = 200406| yahoo = JNJ| google = JNJ:NYSE}}{{Johnson & Johnson}}{{Pharmaceutical companies of the United States}}{{Dow Jones Industrial Average companies}}{{New Brunswick, New Jersey}}{{Authority control}}